Certain industries provided fertile ground for value-based strategies throughout the year:
: Companies like Pfizer (PFE) and Acadia Pharmaceuticals (ACAD) were noted for their attractive entry points, with Acadia viewed as a solid choice for its clinical trial potential. buy low stocks 2017
: Despite "rich" valuations in some areas, many investors found success by "buying the dips" in a momentum-driven rally. buy low stocks 2017
Investors looking for stocks trading at a discount or with significant growth potential identified several key opportunities early in the year: buy low stocks 2017
: Recommended for its healthy balance sheet and high dividend yield (approximately 6.22% at the time), it was considered a strong value play in data storage.